Year archive

Bright Minds Biosciences Inc. — 2023 filings

All 20 regulatory filings released by Bright Minds Biosciences Inc. (DRUG) in 2023, sourced directly from the official regulator.

20 Filings

2023 Period

2023 filings (20)

Filing	Released	Lang
Report of exempt distribution (45-106F1).pdf Regulatory Filings	2023-12-29	English
Cover letter.pdf Share Issue/Capital Change	2023-07-11	English
News release - English.pdf Share Issue/Capital Change	2023-07-11	English
News release - English.pdf Share Issue/Capital Change	2023-06-22	English
News release - English.pdf Regulatory Filings	2023-04-19	English
News release - English.pdf Investor Presentation	2023-04-10	English
Other.pdf Major Shareholding Notification	2023-03-02	English
Notice of meeting - English.pdf AGM Information	2023-03-02	English
Form of proxy - English.pdf AGM Information	2023-03-02	English
Management information circular - English.pdf AGM Information	2023-03-02	English
Other.pdf Report Publication Announcement	2023-03-02	English
News release - English.pdf Capital/Financing Update	2023-02-27	English
News release - English.pdf Board/Management Information	2023-02-17	English
News release - English.pdf Regulatory Filings	2023-02-08	English
Interim MD&A - English.pdf Management Reports	2023-02-07	English
52-109F2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2023-02-07	English
52-109F2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2023-02-07	English
Interim financial statements/report – English.pdf Interim / Quarterly Report	2023-02-07	English
Notice of the meeting and record date - English.pdf AGM Information	2023-01-20	English
News release - English.pdf Board/Management Information	2023-01-09	English